Nan (ln) Li
CIK: 0002131608
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ODTX
Odyssey Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Li Nan (LN)
Li Nan (LN) (SEC CIK 0002131608) files insider reports with the SEC as Director of Odyssey Therapeutics, Inc. (ODTX).
Signal8 holds 2 ownership filings by Li Nan (LN) (1 Form 3, 1 Form 4), filed between May 7, 2026 and May 11, 2026. Those filings report 2 transactions, the latest on May 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Li Nan (LN)'s filings is in BOSTON, MA.
Recent filings by Li Nan (LN)
Other insiders filing for Odyssey Therapeutics, Inc. (ODTX)
- TPG GP A, LLC, Officer
- Dimension Capital II, L.P., Director
- SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner
- LEIDEN JEFFREY M, Director
- Haas Jason, Chief Financial Officer
- SMITH IAN F, Director